FDA Inspection 1161972 — Department of Defense - Navy

Department of Defense - Navy — FEI 1177704

The FDA completed an inspection of Department of Defense - Navy on February 10, 2022 in Fort Belvoir, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 10, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fort Belvoir, VA (United States)

Citations

IDCFRDescription
1503021 CFR 606.60(b)Equipment calibration frequency